[ad_1]
The | New Delhi |
Posted: Apr 22, 2020 4:46:08 AM
“A trained working group ensures that all efforts are made to develop an indigenous vaccine in the near future. India will not miss any opportunity to be the world center for vaccine development and manufacturing, ”said Dr. Paul.
In the main clear indication from a senior authority official of how long the road is, Dr. V Ok Paul, member (Health), NITI Aayog, has mentioned that India’s resolution within the battle in opposition to the new Coronavirus can be examined within the months of June and July, after confinement restrictions have been alleviated.
“Reducing the blockade is potentially an opportunity for the virus to re-emerge and spread, and this can happen to some degree,” Dr. Paul said in an interview with The Indian Express. “There could be new groups when life and activities become more normal.”
The development of the virus, he said, could be “inversely proportional to our collective compliance with best practices.” We cannot afford to waste the closure gains made at economic cost and phenomenal difficulties. We have to keep virus transmission under control and make sure that no new spikes appear. June and July will test our resolution. “
Lifting the blockade after May 3 could be a “gradual and nuanced issue,” he said.
Dr. Paul, a former professor of pediatrics at AIIMS, is one of the most important people in the planning and execution of the federal government’s COVID administration plan. In addition to his place within NITI Aayog, he chairs the Empowered Group constituted by the Ministry of the Interior on the management plan for medical emergencies, and is a member of the Empowered Group at strategic points associated with the closure, which is headed by the Secretary of the Interior Ajay Bhalla: the one who is part of the 2 Empowered Groups.
Dr. Paul may also be co-chair, along with Prime Minister’s Chief Scientific Advisor Ok VijayRaghavan, of a process pressure that coordinates between scientific companies, scientists, industries and regulatory bodies to make quick decisions on the analysis and the growth associated with the SARS-CoV-2 virus and the COVID-19 disease.
“A trained working group ensures that all efforts are made to develop an indigenous vaccine in the near future. India will not miss any opportunity to be the world center for vaccine development and manufacturing, ”said Dr. Paul.
“ICMR has created a clinical research network and registry to serve as a platform for trials on various therapeutic modalities. These include studying the use of convalescent plasma, plasma exchange, and medications such as redemsivir, etc., when available. ICMR labs are also examining the potential of the new drug molecules for their effect on the virus, “he added.
Don’t miss these articles on Coronavirus Explained part:
‣ How coronavirus attacks, step by step
‣ Mask or not mask? Why has the orientation changed?
‣ In addition to a face covering, should I wear gloves when I go outdoors?
‣ How Agra, Bhilwara and Pathanamthitta Covid-19 containment models differ
‣ Can coronavirus harm your brain?
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and keep up to date with the latest headlines.
For all the news from India, get the Indian Express app.
